Ghent University Academic Bibliography

Mark

Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease : a case report

Eva De Backer, Félix Gremonprez (UGent) , Guy Brusselle (UGent) , Pieter Depuydt (UGent) , Jo Van Dorpe (UGent) , Carole Van Haverbeke (UGent) , Pieter Goeminne and Eric Derom (UGent)

(2018) ACTA CLINICA BELGICA. 73(6). p.413-417

Mark

journalArticle
open access

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

Robert J. Kreitman, Claire Dearden, Pier Luigi Zinzani, Julio Delgado, Lionel Karlin, Tadeusz Robak, Douglas E. Gladstone, Philipp le Coutre, Sascha Dietrich, Mirjana Gotic, et al.

(2018) LEUKEMIA. 32(8). p.1768-1777

Mark

journalArticle
A1
open access

A longitudinal analysis of IDO and PDL1 expression during immune- or targeted therapy in advanced melanoma

Lukas Krähenbühl, Simone M Goldinger, Joanna Mangana, Katrin Kerl, Ines Chevolet, Lieve Brochez (UGent) , Christine Horak, Mitch Levesque, Reinhard Dummer and Phil F Cheng

(2018) NEOPLASIA. 20(2). p.218-225

Mark

Rhinovirus species-specific antibodies differentially reflect clinical outcomes in health and asthma

Spyridon Megremis, Katarzyna Niespodziana, Clarissa Cabauatan, Paraskevi Xepapadaki, Marek L Kowalski, Tuomas Jartti, Claus Bachert (UGent) , Susetta Finotto, Peter West, Sofia Stamataki, et al.

(2018) AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 198(12). p.1490-1499

Mark

Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1

Ahmed Atef Ahmed Abouzeid Mesalam (UGent) , Isabelle Desombere (UGent) , Aliasghar Farhoudi Moghadam (UGent) , Freya Van Houtte (UGent) , Lieven Verhoye (UGent) , Jonathan Ball, Jean Dubuisson, Steven KH Foung, Arvind H Patel, Mats AA Persson, et al.

(2018) VIROLOGY. 514. p.30-41

Mark

Photoinduced cross-linking of short furan-modified DNA on surfaces

Cinthya Véliz Montes, Henry Memczak, Ellen Gyssels (UGent) , Tomás Torres, Annemieke Madder (UGent) and Rudolf J Schneider

(2017) LANGMUIR. 33(5). p.1197-1201

Mark

Reslizumab in eosinophilic asthma : a review

Emma D Deeks and Guy Brusselle (UGent)

(2017) DRUGS. 77(7). p.777-784

Mark

In vitro functional quality characterization of NOTA-modified somatropins

Nathalie Bracke (UGent) , Han Yao (UGent) , Evelien Wynendaele (UGent) , Frederick Verbeke (UGent) , Xiaolong Xu (UGent) , Bert Gevaert (UGent) , Alex Maes, Christophe Van De Wiele (UGent) , Mike Sathekge, Sarah De Saeger (UGent) , et al.

(2017) ANALYTICAL CHEMISTRY. 89(5). p.2764-2772

Mark

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN) : an international, randomised, multi-arm, open-label, phase 3 trial

Ruth Ladenstein, Ulrike Pötschger, Andrew D. J. Pearson, Penelope Brock, Roberto Luksch, Victoria Castel, Isaac Yaniv, Vassilios Papadakis, Genevieve Laureys (UGent) , Josef Malis, et al.

(2017) LANCET ONCOLOGY. 18(4). p.500-514

Mark

Decoration of trastuzumab with short oligonucleotides : synthesis and detailed characterization

Ana Margarida Dias Carvalho Da Rocha (UGent) , Alex Manicardi (UGent) , C Véliz Montes, Smita Gunnoo (UGent) , RJ Schneider and Annemieke Madder (UGent)

(2017) ORGANIC & BIOMOLECULAR CHEMISTRY. 15(42). p.8923-8928

Academic Bibliography

Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease : a case report

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

A longitudinal analysis of IDO and PDL1 expression during immune- or targeted therapy in advanced melanoma

Rhinovirus species-specific antibodies differentially reflect clinical outcomes in health and asthma

Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1

Photoinduced cross-linking of short furan-modified DNA on surfaces

Reslizumab in eosinophilic asthma : a review

In vitro functional quality characterization of NOTA-modified somatropins

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN) : an international, randomised, multi-arm, open-label, phase 3 trial

Decoration of trastuzumab with short oligonucleotides : synthesis and detailed characterization

Contents

Support

Contact